A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis.

A cancer DNA phenotype, identical to the DNA structure of tumors, has been identified in the prostate glands of certain healthy men over 55 years of age. We now show that the same DNA signature exists in normal tissues adjacent to tumors. This finding implies that the phenotype is maintained in normal prostate cells from its inception through tumor development. The presence of the phenotype in tumors, adjacent normal cells, and in the normal prostate cells of certain older men suggests that it is a potentially critical factor in tumor development and may serve as an early biomarker for cancer risk assessment. Intervention to inhibit the development of the phenotype in healthy men, or to eliminate it once formed, may suppress or even prevent tumor formation.

[1]  M. Dizdaroglu.  Oxidative damage to DNA in mammalian chromatin. , 1992, Mutation research.

[2]  Ilya Prigogine,et al.  Order out of chaos , 1984 .

[3]  Donald C. Malins,et al.  A new structural analysis of DNA using statistical models of infrared spectra , 1997, Nature Medicine.

[4]  N. Polissar,et al.  Models of granulocyte DNA structure are highly predictive of myelodysplastic syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Tsuboi.  Application of Infrared Spectroscopy to Structure Studies of Nucleic Acids , 1970 .

[6]  K. Hellström,et al.  Development of a cancer DNA phenotype prior to tumor formation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Gross,et al.  Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. , 2002, Carcinogenesis.

[8]  M. Broggini,et al.  Cell Cycle Checkpoint Proteins and Cellular Response to Treatment by Anticancer Agents , 2004, Cell cycle.

[9]  N. Polissar,et al.  Single 8-oxo-guanine and 8-oxo-adenine lesions induce marked changes in the backbone structure of a 25-base DNA strand. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Bostwick,et al.  High-grade prostatic intraepithelial neoplasia , 2004, Modern Pathology.

[11]  Lloyd D. Fisher,et al.  Biostatistics: A Methodology for the Health Sciences , 1993 .

[12]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[13]  C. Sonntag,et al.  The chemical basis of radiation biology , 1987 .

[14]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Dizdaroglu,et al.  Free radical-induced damage to DNA: mechanisms and measurement. , 2002, Free radical biology & medicine.

[16]  J. Eisinger,et al.  Basic principles in nucleic acid chemistry , 1974 .

[17]  M. Becich,et al.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Zollo,et al.  Unraveling Genes and Pathways Influenced by H-Prune PDE Overexpression: A Model to Study Cellular Motility , 2004, Cell cycle.

[19]  J. T. Wachsman,et al.  DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. , 1997, Mutation research.

[20]  N. Polissar,et al.  Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Wheeler,et al.  Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Szyf.  DNA methylation and cancer therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.